This image is a representation. Your design will be featured in the final product.

Warning: The information provided on this page is for general knowledge purposes only and does not replace the official Instructions for Use (IFU), which are supplied with the medical device. This page does not constitute an electronic IFU either.

NESOSPRAY-KIDS : Rhinosinusitis and Rhinopharyngitis

NESOSPRAY KIDS is an innovative nasal spray designed for the treatment of rhinosinusitis, rhinitis, and rhinopharyngitis in children over 3 years old.

This unique formulation includes a blend of ingredients of vegetal origin.

Available in multiple formulations:

NESOSPRAY (NS) adults
NESOSPRAY HE (NHE) adults
NESOSPRAY HE-G (NHG) adults and children aged twelve (12+) years and over
NESOSPRAY-E (NSE) children aged three (3+) years and over

Clinical trial

Randomized, double-blind, placebo-controlled trial

Population

This product is intended for kids (+3)

Indication

Treatment of sinusistis and rhinosinusitis (common cold)

Patient's benefits

Relieves nasal congestion quickly
Reduces cough intensity fast
Soothes facial pain effectively
Improves sleep from day 3
Decreases overall symptoms rapidly
Boosts daily comfort and well-being
Helps avoid antibiotic use

Mode of action

Protective Barrier: It forms a thin, protective film over the mucosa, creating a mechanical barrier that shields it from direct contact with external agressors such as pathogens and environmental factors that can prolong or exacerbate rhinosinutis.
Mechanical Cleaning: Utilizes osmotic activity to draw out fluids and irritants, cleansing the nasal mucosa, reducing swelling, and alleviating nasal congestion, indirectly addressing inflammation.
Cellular Repair: Promotes healing and regeneration of the mucosa for sustained relief.

Clinical Study

A randomized, double-blind clinical trial confirmed the high efficacy and safety of NESOSPRAY-E in children with acute rhinosinusitis and rhinopharyngitis.

In just 15 days, children treated with NESOSPRAY-E experienced a 98% reduction in nasal congestion and rhinorrhoea, 97% less cough, and 97% less facial pain, with significant improvements observed as early as Day 3. Sleep disturbances were almost completely resolved after one week, and fever cases dropped from 12 to 1.

Importantly, no children in the NESOSPRAY-E group required antibiotics, compared to 40% in the placebo group, demonstrating its ability to reduce reliance on pharmacological interventions.

Overall symptom scores dropped by over 90% by Day 15, confirming rapid and lasting relief. The treatment was well tolerated, with no adverse effects reported.

Conclusion: NESOSPRAY-E is a safe, non-drug, and clinically proven solution for children aged 3 and older, offering fast and effective symptom relief while reducing the need for antibiotics.

Product Details

Indication: Used in children (3+) for the treatment of rhinosinusitis, rhinitis, and rhinopharyngitis.
Composition: Made from vegetal-origin ingredients
Presentation: Nasal spray 15ml.
Class: MDR Class IIa.
Age: 3+.
Storage conditions: Below 25°C.
Legal manufacturer: VITROBIO (France).
Product code: NSE.